Meeting
2011 ASCO Annual Meeting
Concurrent chemoradiotherapy with or without induction chemotherapy for locally advanced head and neck cancer.
Authors
J. J. Caudell
Department of Radiation Oncology, University of Mississippi Medical Center, Jackson, MS
J. J. Caudell , S. Spencer , R. Meredith , L. Nabell , J. A. Bonner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Head and Neck Cancer
Citation
J Clin Oncol 29: 2011 (suppl; abstr 5553)
Abstract #
5553
Poster Bd #
13H
Abstract Disclosures
Similar Posters
Poster
2015 Gastrointestinal Cancers Symposium
Paclitaxel, carboplatin, and capecitabine (TCX) with and without radiation in locally advanced and metastatic distal esophageal and esophagogastric junction cancer: A single-center retrospective review.
First Author: Peter Joel Hosein
Poster
2014 ASCO Annual Meeting
Randomized phase II trial of weekly paclitaxel, carboplatin, cetuximab (PCC) versus cetuximab, docetaxel, cisplatin, and fluorouracil (C-TPF) in previously untreated patients with locally advanced head and neck squamous cell carcinoma.
First Author: Erminia Massarelli
Poster
2012 ASCO Annual Meeting
Response of chemoradiation therapy after induction chemotherapy failure in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
First Author: Yoojoo Lim
Poster
2023 ASCO Annual Meeting
Induction chemotherapy with nanosomal docetaxel lipid suspension (NDLS), cisplatin, and fluorouracil in patients with locally advanced head and neck squamous cell carcinoma.
First Author: Ghanashyam Biswas